AIDS Weekly
Susan Hasty, Publisher
Table of Contents . . . September 23rd, 2002
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in AIDS Weekly | Other Publications
HIV/AIDS Diagnosis - Controversial rapid screen effective after occupational exposure
HIV/AIDS Therapy - Arginine treatment may improve immune function
Critical Care - Significantly improved survival in intensive care seen for HIV patients
HIV/AIDS Therapy - Lopinavir and ritonavir superior to nelfinavir-based regimens
HIV/AIDS Therapy - Murabatide safely improves immune response to infection
HIV/AIDS Wasting Syndrome - Cosmetic surgery can restore facial appearance
AIDS Therapy - Manufacturer says Chinese version of anti-AIDS drug to reach patients by end of year
AIDS Therapy - Norzyme awarded grant by National Institutes of Health
AIDS Therapy - Orathecin receives orphan-drug designation for treatment of pediatric AIDS
AIDS Therapy - Roche and Trimeris open physician enrollment for Fuzeon early access program
Appointments - Triangle Pharmaceuticals names Daniel G. Welch chairman and CEO
Biologics - VaxGen joint venture to buy 24 acres in South Korea
Drug Resistance - ViroLogic: Data on increase in HIV drug resistance published
Finance - Antiviral-focused company announces second quarter 2002 financial results
Finance - Revenues increase 18.2% for infectious disease detection and monitoring company
Finance - Second quarter 2002 financial results reported by gene, cell therapy technology
HIV/AIDS Monitoring - Improved HIV viral load test approved by FDA
HIV/AIDS Therapy - Abacavir substitution has limited benefits for lipoatrophy patients
HIV/AIDS Therapy - Pediatric antiretroviral treatment should target nervous system infection
HIV/AIDS Therapy - Sunesis receives NIH grant to develop new HIV therapies
Interleukin-2 Inhibitor - Company achieves research breakthrough using tethering technology
Obstetrics - Thai hospital claims reduced mother-baby transmission
Restructuring - Operational changes announced
Sociology - Activism may help those with AIDS cope better with illness
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
